nodes	percent_of_prediction	percent_of_DWPC	metapath
Mycophenolate mofetil—ABCG2—Teniposide—lymphatic system cancer	0.103	0.152	CbGbCtD
Mycophenolate mofetil—ABCG2—Mitoxantrone—lymphatic system cancer	0.0717	0.107	CbGbCtD
Mycophenolate mofetil—SLCO1B3—Methotrexate—lymphatic system cancer	0.0646	0.0959	CbGbCtD
Mycophenolate mofetil—CYP3A5—Teniposide—lymphatic system cancer	0.0568	0.0844	CbGbCtD
Mycophenolate mofetil—ABCC2—Vincristine—lymphatic system cancer	0.0546	0.0811	CbGbCtD
Mycophenolate mofetil—ABCG2—Vincristine—lymphatic system cancer	0.0494	0.0733	CbGbCtD
Mycophenolate mofetil—SLCO1B1—Methotrexate—lymphatic system cancer	0.0376	0.0559	CbGbCtD
Mycophenolate mofetil—ABCC2—Methotrexate—lymphatic system cancer	0.0331	0.0491	CbGbCtD
Mycophenolate mofetil—ABCG2—Methotrexate—lymphatic system cancer	0.0299	0.0444	CbGbCtD
Mycophenolate mofetil—CYP3A5—Vincristine—lymphatic system cancer	0.0273	0.0406	CbGbCtD
Mycophenolate mofetil—ABCB1—Mitoxantrone—lymphatic system cancer	0.0259	0.0384	CbGbCtD
Mycophenolate mofetil—CYP3A4—Cytarabine—lymphatic system cancer	0.0225	0.0334	CbGbCtD
Mycophenolate mofetil—CYP3A4—Teniposide—lymphatic system cancer	0.0222	0.0329	CbGbCtD
Mycophenolate mofetil—ALB—Methotrexate—lymphatic system cancer	0.0206	0.0306	CbGbCtD
Mycophenolate mofetil—ABCB1—Vincristine—lymphatic system cancer	0.0178	0.0264	CbGbCtD
Mycophenolate mofetil—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0155	0.023	CbGbCtD
Mycophenolate mofetil—ABCB1—Methotrexate—lymphatic system cancer	0.0108	0.016	CbGbCtD
Mycophenolate mofetil—CYP3A4—Vincristine—lymphatic system cancer	0.0107	0.0158	CbGbCtD
Mycophenolate mofetil—Gynaecomastia—Methotrexate—lymphatic system cancer	0.000222	0.000679	CcSEcCtD
Mycophenolate mofetil—Alopecia—Mitoxantrone—lymphatic system cancer	0.000221	0.000676	CcSEcCtD
Mycophenolate mofetil—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.000221	0.000676	CcSEcCtD
Mycophenolate mofetil—Confusional state—Bleomycin—lymphatic system cancer	0.000221	0.000675	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00022	0.000673	CcSEcCtD
Mycophenolate mofetil—Tremor—Carmustine—lymphatic system cancer	0.000219	0.000671	CcSEcCtD
Mycophenolate mofetil—Oedema—Bleomycin—lymphatic system cancer	0.000219	0.00067	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000219	0.00067	CcSEcCtD
Mycophenolate mofetil—Infection—Bleomycin—lymphatic system cancer	0.000217	0.000665	CcSEcCtD
Mycophenolate mofetil—Anaemia—Carmustine—lymphatic system cancer	0.000216	0.000662	CcSEcCtD
Mycophenolate mofetil—Back pain—Vincristine—lymphatic system cancer	0.000216	0.000662	CcSEcCtD
Mycophenolate mofetil—Vomiting—Teniposide—lymphatic system cancer	0.000216	0.000661	CcSEcCtD
Mycophenolate mofetil—Sepsis—Methotrexate—lymphatic system cancer	0.000215	0.000659	CcSEcCtD
Mycophenolate mofetil—Agitation—Carmustine—lymphatic system cancer	0.000215	0.000658	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000214	0.000656	CcSEcCtD
Mycophenolate mofetil—Asthenia—Fludarabine—lymphatic system cancer	0.000214	0.000655	CcSEcCtD
Mycophenolate mofetil—Rash—Teniposide—lymphatic system cancer	0.000214	0.000655	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Teniposide—lymphatic system cancer	0.000214	0.000655	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000213	0.000652	CcSEcCtD
Mycophenolate mofetil—Headache—Teniposide—lymphatic system cancer	0.000213	0.000651	CcSEcCtD
Mycophenolate mofetil—Pruritus—Fludarabine—lymphatic system cancer	0.000211	0.000646	CcSEcCtD
Mycophenolate mofetil—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000211	0.000646	CcSEcCtD
Mycophenolate mofetil—Back pain—Mitoxantrone—lymphatic system cancer	0.00021	0.000644	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Carmustine—lymphatic system cancer	0.000209	0.000641	CcSEcCtD
Mycophenolate mofetil—Anorexia—Bleomycin—lymphatic system cancer	0.000209	0.000638	CcSEcCtD
Mycophenolate mofetil—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.000208	0.000637	CcSEcCtD
Mycophenolate mofetil—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.000207	0.000633	CcSEcCtD
Mycophenolate mofetil—Anaemia—Vincristine—lymphatic system cancer	0.000206	0.000632	CcSEcCtD
Mycophenolate mofetil—Agitation—Vincristine—lymphatic system cancer	0.000205	0.000628	CcSEcCtD
Mycophenolate mofetil—Hypotension—Bleomycin—lymphatic system cancer	0.000204	0.000626	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Fludarabine—lymphatic system cancer	0.000204	0.000625	CcSEcCtD
Mycophenolate mofetil—Convulsion—Carmustine—lymphatic system cancer	0.000203	0.000621	CcSEcCtD
Mycophenolate mofetil—Hypertension—Carmustine—lymphatic system cancer	0.000202	0.000619	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000202	0.000618	CcSEcCtD
Mycophenolate mofetil—Nausea—Teniposide—lymphatic system cancer	0.000202	0.000617	CcSEcCtD
Mycophenolate mofetil—Anaemia—Mitoxantrone—lymphatic system cancer	0.000201	0.000616	CcSEcCtD
Mycophenolate mofetil—Vertigo—Vincristine—lymphatic system cancer	0.000201	0.000614	CcSEcCtD
Mycophenolate mofetil—Hepatic failure—Methotrexate—lymphatic system cancer	0.0002	0.000613	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Vincristine—lymphatic system cancer	0.0002	0.000612	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000199	0.00061	CcSEcCtD
Mycophenolate mofetil—Chest pain—Carmustine—lymphatic system cancer	0.000199	0.00061	CcSEcCtD
Mycophenolate mofetil—Myalgia—Carmustine—lymphatic system cancer	0.000199	0.00061	CcSEcCtD
Mycophenolate mofetil—Anxiety—Carmustine—lymphatic system cancer	0.000199	0.000608	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Bleomycin—lymphatic system cancer	0.000196	0.000601	CcSEcCtD
Mycophenolate mofetil—Malaise—Mitoxantrone—lymphatic system cancer	0.000196	0.000601	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Bleomycin—lymphatic system cancer	0.000195	0.000597	CcSEcCtD
Mycophenolate mofetil—Renal failure acute—Methotrexate—lymphatic system cancer	0.000195	0.000597	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000195	0.000596	CcSEcCtD
Mycophenolate mofetil—Convulsion—Vincristine—lymphatic system cancer	0.000194	0.000593	CcSEcCtD
Mycophenolate mofetil—Hypertension—Vincristine—lymphatic system cancer	0.000193	0.00059	CcSEcCtD
Mycophenolate mofetil—Confusional state—Carmustine—lymphatic system cancer	0.000193	0.00059	CcSEcCtD
Mycophenolate mofetil—Oedema—Carmustine—lymphatic system cancer	0.000191	0.000585	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Bleomycin—lymphatic system cancer	0.00019	0.000582	CcSEcCtD
Mycophenolate mofetil—Myalgia—Vincristine—lymphatic system cancer	0.00019	0.000582	CcSEcCtD
Mycophenolate mofetil—Visual disturbance—Methotrexate—lymphatic system cancer	0.00019	0.000581	CcSEcCtD
Mycophenolate mofetil—Cough—Mitoxantrone—lymphatic system cancer	0.00019	0.000581	CcSEcCtD
Mycophenolate mofetil—Infection—Carmustine—lymphatic system cancer	0.00019	0.000581	CcSEcCtD
Mycophenolate mofetil—Vomiting—Fludarabine—lymphatic system cancer	0.00019	0.000581	CcSEcCtD
Mycophenolate mofetil—Convulsion—Mitoxantrone—lymphatic system cancer	0.000189	0.000577	CcSEcCtD
Mycophenolate mofetil—Rash—Fludarabine—lymphatic system cancer	0.000188	0.000576	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Fludarabine—lymphatic system cancer	0.000188	0.000575	CcSEcCtD
Mycophenolate mofetil—Hypertension—Mitoxantrone—lymphatic system cancer	0.000188	0.000575	CcSEcCtD
Mycophenolate mofetil—Pain—Bleomycin—lymphatic system cancer	0.000187	0.000573	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000187	0.000572	CcSEcCtD
Mycophenolate mofetil—Headache—Fludarabine—lymphatic system cancer	0.000187	0.000572	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Carmustine—lymphatic system cancer	0.000186	0.000571	CcSEcCtD
Mycophenolate mofetil—Chest pain—Mitoxantrone—lymphatic system cancer	0.000185	0.000567	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000185	0.000567	CcSEcCtD
Mycophenolate mofetil—Myalgia—Mitoxantrone—lymphatic system cancer	0.000185	0.000567	CcSEcCtD
Mycophenolate mofetil—Anxiety—Mitoxantrone—lymphatic system cancer	0.000185	0.000565	CcSEcCtD
Mycophenolate mofetil—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000184	0.000562	CcSEcCtD
Mycophenolate mofetil—Discomfort—Mitoxantrone—lymphatic system cancer	0.000183	0.00056	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000182	0.000558	CcSEcCtD
Mycophenolate mofetil—Oedema—Vincristine—lymphatic system cancer	0.000182	0.000558	CcSEcCtD
Mycophenolate mofetil—Anorexia—Carmustine—lymphatic system cancer	0.000182	0.000557	CcSEcCtD
Mycophenolate mofetil—Infection—Vincristine—lymphatic system cancer	0.000181	0.000554	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00018	0.000552	CcSEcCtD
Mycophenolate mofetil—Osteoarthritis—Methotrexate—lymphatic system cancer	0.00018	0.000551	CcSEcCtD
Mycophenolate mofetil—Confusional state—Mitoxantrone—lymphatic system cancer	0.000179	0.000548	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Vincristine—lymphatic system cancer	0.000179	0.000547	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000179	0.000546	CcSEcCtD
Mycophenolate mofetil—Hypotension—Carmustine—lymphatic system cancer	0.000178	0.000546	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000178	0.000544	CcSEcCtD
Mycophenolate mofetil—Oedema—Mitoxantrone—lymphatic system cancer	0.000178	0.000544	CcSEcCtD
Mycophenolate mofetil—Nausea—Fludarabine—lymphatic system cancer	0.000177	0.000543	CcSEcCtD
Mycophenolate mofetil—Infection—Mitoxantrone—lymphatic system cancer	0.000176	0.00054	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000176	0.00054	CcSEcCtD
Mycophenolate mofetil—Shock—Mitoxantrone—lymphatic system cancer	0.000175	0.000535	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000174	0.000533	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000174	0.000532	CcSEcCtD
Mycophenolate mofetil—Urticaria—Bleomycin—lymphatic system cancer	0.000174	0.000532	CcSEcCtD
Mycophenolate mofetil—Anorexia—Vincristine—lymphatic system cancer	0.000174	0.000532	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000173	0.00053	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Bleomycin—lymphatic system cancer	0.000173	0.00053	CcSEcCtD
Mycophenolate mofetil—Insomnia—Carmustine—lymphatic system cancer	0.000173	0.000529	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000172	0.000528	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000172	0.000525	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Carmustine—lymphatic system cancer	0.000172	0.000525	CcSEcCtD
Mycophenolate mofetil—Mood swings—Methotrexate—lymphatic system cancer	0.000171	0.000522	CcSEcCtD
Mycophenolate mofetil—Hypotension—Vincristine—lymphatic system cancer	0.00017	0.000522	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Carmustine—lymphatic system cancer	0.00017	0.000521	CcSEcCtD
Mycophenolate mofetil—Somnolence—Carmustine—lymphatic system cancer	0.00017	0.00052	CcSEcCtD
Mycophenolate mofetil—Anorexia—Mitoxantrone—lymphatic system cancer	0.000169	0.000518	CcSEcCtD
Mycophenolate mofetil—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000166	0.000509	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000166	0.000509	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Carmustine—lymphatic system cancer	0.000166	0.000508	CcSEcCtD
Mycophenolate mofetil—Hypotension—Mitoxantrone—lymphatic system cancer	0.000166	0.000508	CcSEcCtD
Mycophenolate mofetil—Insomnia—Vincristine—lymphatic system cancer	0.000165	0.000505	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000165	0.000505	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Vincristine—lymphatic system cancer	0.000164	0.000501	CcSEcCtD
Mycophenolate mofetil—Constipation—Carmustine—lymphatic system cancer	0.000163	0.0005	CcSEcCtD
Mycophenolate mofetil—Pain—Carmustine—lymphatic system cancer	0.000163	0.0005	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000162	0.000495	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000161	0.000493	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000159	0.000488	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Vincristine—lymphatic system cancer	0.000158	0.000485	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000158	0.000485	CcSEcCtD
Mycophenolate mofetil—Somnolence—Mitoxantrone—lymphatic system cancer	0.000158	0.000483	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000157	0.000482	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Carmustine—lymphatic system cancer	0.000157	0.000482	CcSEcCtD
Mycophenolate mofetil—Asthenia—Bleomycin—lymphatic system cancer	0.000157	0.000481	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000156	0.000478	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000156	0.000478	CcSEcCtD
Mycophenolate mofetil—Pain—Vincristine—lymphatic system cancer	0.000156	0.000477	CcSEcCtD
Mycophenolate mofetil—Constipation—Vincristine—lymphatic system cancer	0.000156	0.000477	CcSEcCtD
Mycophenolate mofetil—Asthma—Methotrexate—lymphatic system cancer	0.000156	0.000476	CcSEcCtD
Mycophenolate mofetil—Pruritus—Bleomycin—lymphatic system cancer	0.000155	0.000474	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000154	0.000473	CcSEcCtD
Mycophenolate mofetil—Pancreatitis—Methotrexate—lymphatic system cancer	0.000153	0.000467	CcSEcCtD
Mycophenolate mofetil—Constipation—Mitoxantrone—lymphatic system cancer	0.000152	0.000465	CcSEcCtD
Mycophenolate mofetil—Pain—Mitoxantrone—lymphatic system cancer	0.000152	0.000465	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Carmustine—lymphatic system cancer	0.000151	0.000462	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Carmustine—lymphatic system cancer	0.000151	0.000462	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000149	0.000456	CcSEcCtD
Mycophenolate mofetil—Pancytopenia—Methotrexate—lymphatic system cancer	0.000148	0.000452	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000146	0.000448	CcSEcCtD
Mycophenolate mofetil—Dysuria—Methotrexate—lymphatic system cancer	0.000145	0.000445	CcSEcCtD
Mycophenolate mofetil—Neutropenia—Methotrexate—lymphatic system cancer	0.000145	0.000445	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000145	0.000444	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Vincristine—lymphatic system cancer	0.000144	0.000441	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Vincristine—lymphatic system cancer	0.000144	0.000441	CcSEcCtD
Mycophenolate mofetil—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000143	0.000439	CcSEcCtD
Mycophenolate mofetil—Urticaria—Mitoxantrone—lymphatic system cancer	0.000141	0.000432	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Carmustine—lymphatic system cancer	0.000141	0.000431	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00014	0.00043	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00014	0.00043	CcSEcCtD
Mycophenolate mofetil—Pneumonia—Methotrexate—lymphatic system cancer	0.00014	0.000427	CcSEcCtD
Mycophenolate mofetil—Vomiting—Bleomycin—lymphatic system cancer	0.000139	0.000426	CcSEcCtD
Mycophenolate mofetil—Infestation—Methotrexate—lymphatic system cancer	0.000139	0.000425	CcSEcCtD
Mycophenolate mofetil—Infestation NOS—Methotrexate—lymphatic system cancer	0.000139	0.000425	CcSEcCtD
Mycophenolate mofetil—Depression—Methotrexate—lymphatic system cancer	0.000138	0.000423	CcSEcCtD
Mycophenolate mofetil—Rash—Bleomycin—lymphatic system cancer	0.000138	0.000422	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Bleomycin—lymphatic system cancer	0.000138	0.000422	CcSEcCtD
Mycophenolate mofetil—Asthenia—Carmustine—lymphatic system cancer	0.000137	0.000419	CcSEcCtD
Mycophenolate mofetil—Renal failure—Methotrexate—lymphatic system cancer	0.000136	0.000417	CcSEcCtD
Mycophenolate mofetil—Stomatitis—Methotrexate—lymphatic system cancer	0.000135	0.000414	CcSEcCtD
Mycophenolate mofetil—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000135	0.000413	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Vincristine—lymphatic system cancer	0.000134	0.000411	CcSEcCtD
Mycophenolate mofetil—Sweating—Methotrexate—lymphatic system cancer	0.000133	0.000407	CcSEcCtD
Mycophenolate mofetil—Haematuria—Methotrexate—lymphatic system cancer	0.000132	0.000405	CcSEcCtD
Mycophenolate mofetil—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000131	0.000402	CcSEcCtD
Mycophenolate mofetil—Epistaxis—Methotrexate—lymphatic system cancer	0.000131	0.000401	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000131	0.0004	CcSEcCtD
Mycophenolate mofetil—Asthenia—Vincristine—lymphatic system cancer	0.000131	0.0004	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Carmustine—lymphatic system cancer	0.000131	0.0004	CcSEcCtD
Mycophenolate mofetil—Nausea—Bleomycin—lymphatic system cancer	0.00013	0.000398	CcSEcCtD
Mycophenolate mofetil—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000129	0.000396	CcSEcCtD
Mycophenolate mofetil—Asthenia—Mitoxantrone—lymphatic system cancer	0.000127	0.00039	CcSEcCtD
Mycophenolate mofetil—Dizziness—Carmustine—lymphatic system cancer	0.000126	0.000387	CcSEcCtD
Mycophenolate mofetil—Haemoglobin—Methotrexate—lymphatic system cancer	0.000125	0.000383	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Vincristine—lymphatic system cancer	0.000125	0.000382	CcSEcCtD
Mycophenolate mofetil—Haemorrhage—Methotrexate—lymphatic system cancer	0.000125	0.000381	CcSEcCtD
Mycophenolate mofetil—Hepatitis—Methotrexate—lymphatic system cancer	0.000125	0.000381	CcSEcCtD
Mycophenolate mofetil—Pharyngitis—Methotrexate—lymphatic system cancer	0.000124	0.000378	CcSEcCtD
Mycophenolate mofetil—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000123	0.000376	CcSEcCtD
Mycophenolate mofetil—Urethral disorder—Methotrexate—lymphatic system cancer	0.000122	0.000374	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000121	0.000372	CcSEcCtD
Mycophenolate mofetil—Vomiting—Carmustine—lymphatic system cancer	0.000121	0.000372	CcSEcCtD
Mycophenolate mofetil—Dizziness—Vincristine—lymphatic system cancer	0.000121	0.000369	CcSEcCtD
Mycophenolate mofetil—Rash—Carmustine—lymphatic system cancer	0.00012	0.000369	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Carmustine—lymphatic system cancer	0.00012	0.000368	CcSEcCtD
Mycophenolate mofetil—Visual impairment—Methotrexate—lymphatic system cancer	0.00012	0.000367	CcSEcCtD
Mycophenolate mofetil—Headache—Carmustine—lymphatic system cancer	0.00012	0.000366	CcSEcCtD
Mycophenolate mofetil—Eye disorder—Methotrexate—lymphatic system cancer	0.000116	0.000356	CcSEcCtD
Mycophenolate mofetil—Tinnitus—Methotrexate—lymphatic system cancer	0.000116	0.000355	CcSEcCtD
Mycophenolate mofetil—Vomiting—Vincristine—lymphatic system cancer	0.000116	0.000355	CcSEcCtD
Mycophenolate mofetil—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000116	0.000354	CcSEcCtD
Mycophenolate mofetil—Rash—Vincristine—lymphatic system cancer	0.000115	0.000352	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Vincristine—lymphatic system cancer	0.000115	0.000352	CcSEcCtD
Mycophenolate mofetil—Headache—Vincristine—lymphatic system cancer	0.000114	0.00035	CcSEcCtD
Mycophenolate mofetil—Nausea—Carmustine—lymphatic system cancer	0.000113	0.000347	CcSEcCtD
Mycophenolate mofetil—Angiopathy—Methotrexate—lymphatic system cancer	0.000113	0.000346	CcSEcCtD
Mycophenolate mofetil—Vomiting—Mitoxantrone—lymphatic system cancer	0.000113	0.000346	CcSEcCtD
Mycophenolate mofetil—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000112	0.000344	CcSEcCtD
Mycophenolate mofetil—Rash—Mitoxantrone—lymphatic system cancer	0.000112	0.000343	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000112	0.000342	CcSEcCtD
Mycophenolate mofetil—Chills—Methotrexate—lymphatic system cancer	0.000112	0.000342	CcSEcCtD
Mycophenolate mofetil—Headache—Mitoxantrone—lymphatic system cancer	0.000111	0.000341	CcSEcCtD
Mycophenolate mofetil—Alopecia—Methotrexate—lymphatic system cancer	0.00011	0.000337	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Methotrexate—lymphatic system cancer	0.000109	0.000334	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Methotrexate—lymphatic system cancer	0.000108	0.000332	CcSEcCtD
Mycophenolate mofetil—Nausea—Vincristine—lymphatic system cancer	0.000108	0.000332	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Methotrexate—lymphatic system cancer	0.000106	0.000325	CcSEcCtD
Mycophenolate mofetil—Nausea—Mitoxantrone—lymphatic system cancer	0.000105	0.000323	CcSEcCtD
Mycophenolate mofetil—Back pain—Methotrexate—lymphatic system cancer	0.000105	0.000321	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000101	0.000308	CcSEcCtD
Mycophenolate mofetil—Anaemia—Methotrexate—lymphatic system cancer	0.0001	0.000307	CcSEcCtD
Mycophenolate mofetil—Malaise—Methotrexate—lymphatic system cancer	9.78e-05	0.000299	CcSEcCtD
Mycophenolate mofetil—Vertigo—Methotrexate—lymphatic system cancer	9.74e-05	0.000298	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Methotrexate—lymphatic system cancer	9.7e-05	0.000297	CcSEcCtD
Mycophenolate mofetil—Cough—Methotrexate—lymphatic system cancer	9.46e-05	0.00029	CcSEcCtD
Mycophenolate mofetil—Convulsion—Methotrexate—lymphatic system cancer	9.39e-05	0.000288	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Methotrexate—lymphatic system cancer	9.23e-05	0.000283	CcSEcCtD
Mycophenolate mofetil—Myalgia—Methotrexate—lymphatic system cancer	9.23e-05	0.000283	CcSEcCtD
Mycophenolate mofetil—Chest pain—Methotrexate—lymphatic system cancer	9.23e-05	0.000283	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	9.16e-05	0.000281	CcSEcCtD
Mycophenolate mofetil—Discomfort—Methotrexate—lymphatic system cancer	9.12e-05	0.000279	CcSEcCtD
Mycophenolate mofetil—Confusional state—Methotrexate—lymphatic system cancer	8.92e-05	0.000273	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Methotrexate—lymphatic system cancer	8.85e-05	0.000271	CcSEcCtD
Mycophenolate mofetil—Infection—Methotrexate—lymphatic system cancer	8.79e-05	0.000269	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Methotrexate—lymphatic system cancer	8.68e-05	0.000266	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Methotrexate—lymphatic system cancer	8.66e-05	0.000265	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Methotrexate—lymphatic system cancer	8.59e-05	0.000263	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Methotrexate—lymphatic system cancer	8.55e-05	0.000262	CcSEcCtD
Mycophenolate mofetil—Anorexia—Methotrexate—lymphatic system cancer	8.43e-05	0.000258	CcSEcCtD
Mycophenolate mofetil—Hypotension—Methotrexate—lymphatic system cancer	8.27e-05	0.000253	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	8.06e-05	0.000247	CcSEcCtD
Mycophenolate mofetil—Insomnia—Methotrexate—lymphatic system cancer	8e-05	0.000245	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Methotrexate—lymphatic system cancer	7.94e-05	0.000243	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Methotrexate—lymphatic system cancer	7.89e-05	0.000241	CcSEcCtD
Mycophenolate mofetil—Somnolence—Methotrexate—lymphatic system cancer	7.86e-05	0.000241	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Methotrexate—lymphatic system cancer	7.79e-05	0.000238	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Methotrexate—lymphatic system cancer	7.69e-05	0.000235	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	7.64e-05	0.000234	CcSEcCtD
Mycophenolate mofetil—Pain—Methotrexate—lymphatic system cancer	7.57e-05	0.000232	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Methotrexate—lymphatic system cancer	7.29e-05	0.000223	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Methotrexate—lymphatic system cancer	7.23e-05	0.000221	CcSEcCtD
Mycophenolate mofetil—Urticaria—Methotrexate—lymphatic system cancer	7.03e-05	0.000215	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Methotrexate—lymphatic system cancer	6.99e-05	0.000214	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Methotrexate—lymphatic system cancer	6.99e-05	0.000214	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Methotrexate—lymphatic system cancer	6.52e-05	0.0002	CcSEcCtD
Mycophenolate mofetil—Asthenia—Methotrexate—lymphatic system cancer	6.35e-05	0.000194	CcSEcCtD
Mycophenolate mofetil—Pruritus—Methotrexate—lymphatic system cancer	6.26e-05	0.000192	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Methotrexate—lymphatic system cancer	6.05e-05	0.000185	CcSEcCtD
Mycophenolate mofetil—Dizziness—Methotrexate—lymphatic system cancer	5.85e-05	0.000179	CcSEcCtD
Mycophenolate mofetil—Vomiting—Methotrexate—lymphatic system cancer	5.62e-05	0.000172	CcSEcCtD
Mycophenolate mofetil—Rash—Methotrexate—lymphatic system cancer	5.58e-05	0.000171	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Methotrexate—lymphatic system cancer	5.57e-05	0.000171	CcSEcCtD
Mycophenolate mofetil—Headache—Methotrexate—lymphatic system cancer	5.54e-05	0.00017	CcSEcCtD
Mycophenolate mofetil—Nausea—Methotrexate—lymphatic system cancer	5.25e-05	0.000161	CcSEcCtD
